Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Acute Myeloid Leukemia Occurring in Responders to the 9/11 Attack on the World Trade Center: A Single Institution Case Series

Steven L. Allen, MD, Ruthee-Lu Bayer, MD, Dilip Patel, MD, Jonathan E. Kolitz, MD

Blood (2008) 112 (11): 3997.

https://doi.org/10.1182/blood.V112.11.3997.3997

Published: 2008

Journal Articles

Leukocyte Alkaline Phosphatase Score as a Marker of Severity and Progression of Myelodysplastic Syndrome.

Jay Lipshitz, MD, Sewanti Limaye, MD, Dilip Patel, MD

Blood (2007) 110 (11): 4625.

https://doi.org/10.1182/blood.V110.11.4625.4625

Published: 2007

Journal Articles

Treatment of Myelodysplastic Syndrome with Azacitidine and Erythropoietin .

Sewanti Limaye, MD, Jay Lipshitz, MD, Renuka Dulala, MD, Dilip Patel, MD

Blood (2007) 110 (11): 4627.

https://doi.org/10.1182/blood.V110.11.4627.4627

Published: 2007

Journal Articles

A Combination of Rituxan, Cyclophosphamide and Dexamethasone (RCD) Results in Long-Lasting Responses in Autoimmune Anemia and Thrombocytopenia in CLL Patients: A Single Institution Study.

Matthew S. Kaufman, MD, Yehuda Z. Lebowicz, MD, Nancy Driscoll, RPA-C, Christina Johnson, RPA-C, Dale Janson, RPA-C, Angelica Caramanica, RPA-C, Rajasree Roy, MD, Neetu Radhakrishnan, MD, Dhaval Mehta, MD, Mark Hoffman, MD, Dilip Patel, MD, Nina Kohn, MBA,MA, Kanti R. Rai, MD

Blood (2006) 108 (11): 2832.

https://doi.org/10.1182/blood.V108.11.2832.2832

Published: 2006

Journal Articles

Response to Rituximab, Cyclophosphamide and Dexamethasone as Initial or Salvage Therapy in Low Grade Lymphoma and Immune Hemolytic Anemia.

Neetu Radhakrishnan, MD, Rajasree Roy, MD, Reuven Yakubov, MD, Matthew Kaufman, MD, Kanti Rai, MD, Bhoomi Mehrotra, MD, Dilip Patel, MD

Blood (2006) 108 (11): 4726.

https://doi.org/10.1182/blood.V108.11.4726.4726

Published: 2006

Journal Articles

Leukocyte Alkaline Phosphatase Score in Myelodysplastic Syndrome: A Comparison of Patients with Normal and Abnormal Proportions of Bone Marrow Blasts.

Jay Lipshitz, MD, Natalie Tafel, RPAC, Dilip Patel, MD

Blood (2006) 108 (11): 4865.

https://doi.org/10.1182/blood.V108.11.4865.4865

Published: 2006

NARROW

Acute Myeloid Leukemia Occurring in Responders to the 9/11 Attack on the World Trade Center: A Single Institution Case Series

Leukocyte Alkaline Phosphatase Score as a Marker of Severity and Progression of Myelodysplastic Syndrome.

Treatment of Myelodysplastic Syndrome with Azacitidine and Erythropoietin .

A Combination of Rituxan, Cyclophosphamide and Dexamethasone (RCD) Results in Long-Lasting Responses in Autoimmune Anemia and Thrombocytopenia in CLL Patients: A Single Institution Study.

Response to Rituximab, Cyclophosphamide and Dexamethasone as Initial or Salvage Therapy in Low Grade Lymphoma and Immune Hemolytic Anemia.

Leukocyte Alkaline Phosphatase Score in Myelodysplastic Syndrome: A Comparison of Patients with Normal and Abnormal Proportions of Bone Marrow Blasts.

Email alerts

ASH Publications

American Society of Hematology

Acute Myeloid Leukemia Occurring in Responders to the 9/11 Attack on the World Trade Center: A Single Institution Case Series

Leukocyte Alkaline Phosphatase Score as a Marker of Severity and Progression of Myelodysplastic Syndrome.

Treatment of Myelodysplastic Syndrome with Azacitidine and Erythropoietin .

A Combination of Rituxan, Cyclophosphamide and Dexamethasone (RCD) Results in Long-Lasting Responses in Autoimmune Anemia and Thrombocytopenia in CLL Patients: A Single Institution Study.

Response to Rituximab, Cyclophosphamide and Dexamethasone as Initial or Salvage Therapy in Low Grade Lymphoma and Immune Hemolytic Anemia.

Leukocyte Alkaline Phosphatase Score in Myelodysplastic Syndrome: A Comparison of Patients with Normal and Abnormal Proportions of Bone Marrow Blasts.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only